Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention. by Elad Ziv, Jeffrey A Tice, Brian Sprague, Celine M Vachon, Steven R Cummings, Karla Kerlikowske

Get full text

National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling by Martin Eklund, Kimberly Badal, James Staib, Jeffrey A. Tice, Mi-Ok Kim, Leslie Wilson, Stacey Dacosta Byfield, Kierstin Catlett, Liz Maffey, Rashna Soonavala, Yiwey Shieh, Laura J. Esserman

Get full text

Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial by Holly Keane, Yash S. Huilgol, Yiwey Shieh, Jeffrey A. Tice, Jeff Belkora, Karen Sepucha, W. Patrick Shibley, Tianyi Wang, Mandy Che, Deborah Goodman, Elissa Ozanne, Allison Stover Fiscalini, Laura J. Esserman

Get full text

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry by Yash S. Huilgol, Holly Keane, Yiwey Shieh, Robert A. Hiatt, Jeffrey A. Tice, Lisa Madlensky, Leah Sabacan, Allison Stover Fiscalini, Elad Ziv, Irene Acerbi, Mandy Che, Hoda Anton-Culver, Alexander D. Borowsky, Sharon Hunt, Arash Naeim, Barbara A. Parker, Laura J. van ‘T Veer, Athena Breast Health Network Investigators and Advocate Partners, Laura J. Esserman

Get full text